BioCentury
ARTICLE | Company News

Ablexis deal

July 16, 2012 7:00 AM UTC

Ablexis granted an undisclosed pharmaceutical company non-exclusive rights to AlivaMab Mouse transgenic mouse technology to discover human antibodies. The pharma will make a "seven-figure pre-delivery...